Mar 13th 2007
A
'state-of-the-art' presentation:
"Prostate
Cancer and Cellular Repair-The new LEGEND program
at Princess Margaret Hospital"
by Dr. Robert Bristow
Dr. Bristow's talk was
attended by an eager audience of around 80 members, wives, guests and some
first timers.
In this informative talk, Dr. Robert Bristow reviewed
the state of current and future testing
and the direction that research, in the form of the new Legend Program at
PMH, is playing
in determining the best forms of treatment for different individuals. This
research and the
development of these new tests may help us understand who is at risk for
prostate cancer
based on the presence of low oxygen levels in the prostate and faulty
cellular DNA repair
mechanisms. The ultimate goal of the new Legend Program at Princess
Margaret Hospital
is to provide the best treatment for a specific patient with minimal side
effects.
Dr. Bristow discussed how DNA and chromosomes are damaged by day to day
insults and
how they are normally repaired by our cells as well as how prostate cancer
may develop
because of faulty cellular repair which allows for the growth of mutant
cells and the
development of cancer. He demonstrated the connection between low oxygen
levels within
the prostate and the accelerated development of prostate cancer.
Dr. Bristow described the development of new therapies that target
aggressive repair-deficient
cancer cells. He also described how CT scans during radiation treatments
help focus treatment
directly on the affected areas of the prostate gland. Further research at
Princess Margaret has
also found a link between hormone therapy and improved radiation therapy
results. It seems that
Casodex actually helps improve the oxygenation levels of the prostate,
making it more responsive
to radiation therapy.
Dr. Bristow’s talk was both an informative and uplifting look into the
world of prostate cancer research.
The "Dream is Alive", were
words we used to describe Dr. Bristow's last talk (Nov 03) to our group.
Listening to this - his latest presentation, and a sequel, on the pursuit
of that dream - one could be more
hopeful that at some point in the future Prostate Cancer might become
manageable on 'a-pill-a-day' basis.
After his talk Dr. Bristow spent some time answering
questions and talking to the group
about the new “Crusin For A Cure Canada” event.
He was subsequently instrumental in prompting a follow-up meeting with
Princess Margaret
Hospital staff to determine what level of support they may be able to
provide us.
About Dr. Bristow:
Dr. Bristow has a brilliant background
with degrees, cholarships, awards, research, positions and
publications too numerous to list here. He is involved across a vast scope
of research activities and
programs both provincially and at international levels.
Amongst the key positions he holds currently are:
* Clinician-Scientist, Ontario Cancer Institute and Princess Margaret
Hospital (University Health Network)
* Associate Professor, Depts. Radiation Oncology and Medical Biophysics,
University of Toronto
*Director, Core I-STTARR and LEGEND Labs Canadian Cancer Society Research
Scientist
* Chair, Scientific and Medical Advisory Committee, Prostate Cancer
Research Foundation of Canada (PCRFC)
* Chair, Biomarkers Planning Committee, Canadian Prostate Cancer Research
Initiative (CPCRI)
* Full Member, Institute of Medical Science (IMS), University of Toronto
Our thanks to Dr. Bristow for both his
valuable time
and for supporting of our cause.
AUDIO & SLIDES DOWNLOADS
AUDIO:
NO AUDIO
AVAILABLE
SLIDES:
Legendprogram